financetom
Business
financetom
/
Business
/
Abbott Laboratories Mpox Test Approved by World Health Organization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Abbott Laboratories Mpox Test Approved by World Health Organization
Oct 4, 2024 8:15 AM

07:37 AM EDT, 10/04/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) mpox in vitro diagnostic assay has been the first such tool approved by the World Health Organization under its emergency use procedures, the multilateral UN agency said Thursday.

The WHO said Abbot's Alinity m MPXV assay will increase diagnostic capacity in countries facing mpox outbreaks. "Early diagnosis of mpox enables timely treatment and care, and control of the virus," the WHO said.

The assay is a real-time PCR test enabling detection of monkeypox virus DNA from human skin lesion swabs.

Price: 112.05, Change: -0.18, Percent Change: -0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Warning letter for Lupin’s Somerset plant disappointing: Sanford Bernstein’s Nithya Balasubramanian
Warning letter for Lupin’s Somerset plant disappointing: Sanford Bernstein’s Nithya Balasubramanian
Jun 16, 2021
Drug major Lupin has received a warning letter from the US health regulator for its Somerset, New Jersey facility. The US FDA had inspected the site from September 10, 2020 to November 5, 2020. Nithya Balasubramanian, Director at Sanford Bernstein expressed her disappointment at this.
CCI plans to expedite antitrust probe against Amazon & Flipkart; experts discuss
CCI plans to expedite antitrust probe against Amazon & Flipkart; experts discuss
Jun 16, 2021
E-commerce majors Amazon and Flipkart are under the competition watchdog's lens. The Competition Commission of India (CCI) plans to expedite a probe into the allegations of anti-competitive behaviour against the two firms. The antitrust probe had begun last year after complaints alleging that the two companies promoted select sellers on their platforms and provided deep discounts that stifled competition.
Sputnik V could be EPS dilutive for Dr Reddy’s: Sanford Bernstein’s Nithya Balasubramanian
Sputnik V could be EPS dilutive for Dr Reddy’s: Sanford Bernstein’s Nithya Balasubramanian
Jun 16, 2021
Sanford Bernstein has an outperform rating on Dr Reddys Laboratories (DRL). Nithya Balasubramanian, Director at Sanford Bernstein, believes that the Sputnik V COVID-19 vaccine could be EPS dilutive for Dr Reddy’s as of now.
Dodla Dairy IPO: Mgmt says focused on value-added products; aims to hit pre-COVID capacity soon
Dodla Dairy IPO: Mgmt says focused on value-added products; aims to hit pre-COVID capacity soon
Jun 16, 2021
Integrated milk products company Dodla Dairy's Rs 520 crore initial public offering (IPO) issue is now open for subscription from Wednesday. To understand the prospects of the company post the IPO issue and the outlook for the business going ahead, CNBC-TV18 spoke to the Managing Director of the company, Sunil Reddy Dodla.
Copyright 2023-2026 - www.financetom.com All Rights Reserved